SCHEMBL1508129

SCHEMBL1508129

COC(=O)CC(=O)c1ccc(O[Si](C)(C)C(C)(C)C)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
LMNA P02545 2/20 0.48
HSD17B10 Q99714 2/20 0.48
ALOX15 P16050 1/20 0.48
APEX1 P27695 1/20 0.48
MAPK1 P28482 1/20 0.48
RECQL P46063 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
PREP P48147 4/20 0.45
KMT2A Q03164 3/20 0.44
MEN1 O00255 1/20 0.44
GSK3B P49841 1/20 0.42
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5032713 0.83 GSK3B (0.59) ALDH1A1LMNAHSD17B10ALOX15APEX1
SCHEMBL7338467 0.83 PREP (0.44) ALDH1A1LMNAHSD17B10ALOX15APEX1
SCHEMBL8906116 0.81 CA1 (0.56) ALDH1A1LMNATDP1PREPKMT2A
SCHEMBL2848014 0.81 MAPT (0.49) ALDH1A1LMNAHSD17B10ALOX15APEX1
SCHEMBL3839217 0.80 CYP4F2 (0.50) ALDH1A1LMNAPREPKMT2AMEN1
SCHEMBL21591852 0.80 STS (0.51) ALDH1A1PREPGSK3BHDAC3HDAC4
SCHEMBL8693803 0.79 KMT2A (0.51) ALDH1A1LMNAHSD17B10PREPKMT2A
SCHEMBL2500559 0.79 ELANE (0.52) LMNAMAPK1PREPKMT2AMEN1
SCHEMBL19020169 0.78 PREP (0.41) ALDH1A1LMNAHSD17B10ALOX15APEX1
SCHEMBL7535671 0.78 F2RL1 (0.46) ALDH1A1LMNAHSD17B10PREPKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2289868-B1 CARBOXYLIC ACID COMPOUND DAIICHI SANKYO CO LTD (JP) 2014-08-13 EP disclosed
US-8222281-B2 Carboxylic acid compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-07-17 US disclosed
US-20110053974-A1 CARBOXYLIC ACID COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-03-03 US disclosed
EP-2289868-A1 CARBOXYLIC ACID COMPOUND Daiichi Sankyo Company, Limited (JP) 2011-03-02 EP disclosed
US-20040254241-A1 Enzyme inhibitor; cognition activators KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-12-16 US disclosed
EP-1431280-A1 ARYL SULFAMATE DERIVATIVES Kyowa Hakko Kogyo Co., Ltd (JP) 2004-06-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053974-A1 CARBOXYLIC ACID COMPOUND AKR1C3, SLC5A1, GPR119 ALDH1A1 195/4885LMNA 2035/4885HSD17B10 112/4885
US-20040254241-A1 Enzyme inhibitor; cognition activators SULT1A1, STS, CYP26A1 ALDH1A1 1187/4885LMNA 4826/4885HSD17B10 182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.